Sugi Predict

Sugi Predict / Compounds / SCHEMBL4484841

SCHEMBL4484841

SCHEMBL4484841

COc1cc(C#N)c(Nc2sc(C(=O)c3ccc(Cl)cc3)c(N)c2C#N)cc1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.64
▸ MAPT P10636 9/20 0.60
▸ MELK Q14680 3/20 0.57
▸ ALDH1A1 P00352 5/20 0.51
▸ HPGD P15428 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ POLB P06746 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ ALOX12 P18054 1/20 0.51
▸ GAA P10253 1/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ CYP2C19 P33261 2/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.47
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL632877 0.85 MAPT (0.67) LMNAMAPTMELKALDH1A1HPGD
SCHEMBL4481501 0.81 ALDH1A1 (0.67) LMNAMAPTMELKALDH1A1HPGD
SCHEMBL632367 0.81 ALDH1A1 (0.67) LMNAMAPTMELKALDH1A1HPGD
SCHEMBL2136562 0.80 MELK (0.66) LMNAMAPTMELKALDH1A1HPGD
SCHEMBL13633822 0.79 ALDH1A1 (0.78) LMNAMAPTMELKALDH1A1HPGD
SCHEMBL632059 0.79 ALDH1A1 (0.67) LMNAMAPTMELKALDH1A1HPGD
SCHEMBL632181 0.78 MAPT (0.68) LMNAMAPTMELKALDH1A1HPGD
SCHEMBL2134407 0.77 MELK (0.66) LMNAMAPTMELKALDH1A1HPGD
SCHEMBL4480170 0.77 ALDH1A1 (0.70) LMNAMAPTMELKALDH1A1HPGD
SCHEMBL632590 0.77 MAPT (0.80) LMNAMAPTMELKALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-20060041006-A1 PDE4B inhibitors and uses therefor PLEXXIKON, INC. 2006-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PDE4B, PDE7B, PDE4A LMNA 2349/4885MAPT 3524/4885MELK 3735/4885
US-20060041006-A1 PDE4B inhibitors and uses therefor PDE4B, PDE7B, PDE4A LMNA 2349/4885MAPT 3524/4885MELK 3735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.